Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Swollen Knee Treatment Market, by Type
6.1 Introduction
6.2 Medications
6.2.1 Corticosteroids
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2 Opioids
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2 Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3 Patient-controlled analgesia (PCA) pumps
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.4 Nerve blocks
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5 Liposomal bupivacaine
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5 Surgery
6.5.1 Arthrocentesis
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5.2 Arthroscopy
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5.3 Knee replacement
6.5.1.1 Total knee replacement
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5.1.2 Uni-compartmental knee replacement
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5.1.3 Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 7. Global Swollen Knee Treatment Market, by End-User
7.1 Introduction
7.2 Hospitals
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3 Clinics
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.4 Ambulatory Surgery Centers
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.5 Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 8. Global Swollen Knee Treatment, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
Chapter 10. Company Profiles
10.1 Stryker Corporation
10.1.1 Company Overview
10.1.2 Type Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Zimmer Holdings
10.2.1 Company Overview
10.2.2 Type Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Smith & Nephew Plc.
10.3.1 Company Overview
10.3.2 Type Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 DePuy Companies Inc.
10.4.1 Company Overview
10.4.2 Technology/Business Segment Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 Wright Medical Group Inc.
10.5.1 Company Overview
10.5.2 Type Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Biomet Inc.
10.6.1 Company Overview
10.6.2 Type Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Exactech
10.7.1 Overview
10.7.2 Type Overview
10.7.3 Financial Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 B. Braun Melsungen AG
10.8.1 Overview
10.8.2 Type/ Technology Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Pfizer Pharmaceuticals, Inc.
10.9.1 Overview
10.9.2 Type Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 Merck & Co.
10.10.1 Overview
10. 10.2 Type Overview
10. 10.3 Financials
10. 10.4 Key Developments
10. 10.5 SWOT Analysis
10.11 Fresenius Kabi
10.11.1 Overview
10. 11.2 Type Overview
10. 11.3 Financials
10. 11.4 Key Developments
10. 11.5 SWOT Analysis
10.12 AngioDynamics
10.12.1 Overview
10.12.2 Type Overview
10.12.3 Financials
10.12.4 Key Developments
10.12.5 SWOT Analysis
10.13 C.R.Bard
10.13.1 Overview
10.13.2 Type Overview
10.13.3 Financials
10.13.4 Key Developments
10.13.5 SWOT Analysis
10.14 Teleflex
10.14.1 Overview
10.14.2 Type Overview
10.14.3 Financials
10.14.4 Key Developments
10.14.5 SWOT Analysis
10.15 Smiths Medical
10.15.1 Overview
10.15.2 Type Overview
10.15.3 Financials
10.15.4 Key Developments
10.15.5 SWOT Analysis
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s Viewpoint
11.1.2 Unmet Needs of the Market
11.2 Key Companies to Watch
11.3 Predictions for the Biosurgery Industry
Chapter 12. Appendix
LIST OF TABLES
Table 1 Global Swollen Knee Treatment Synopsis, 2020–2027
Table 2 Global Swollen Knee Treatment Estimates and Forecast, 2020–2027 (USD Million)
Table 3 Global Swollen Knee Treatment, by Region, 2020–2027 (USD Million)
Table 4 Global Swollen Knee Treatment, by Type, 2020–2027 (USD Million)
Table 6 Global Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 7 North America: Swollen Knee Treatment, by Type, 2020–2027 (USD
Million)
Table 8 North America: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 9 US: Swollen Knee Treatment, by Type, 2020–2027 (USD Million)
Table 10 US: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 11 Canada: Swollen Knee Treatment, by Type, 2020–2027 (USD Million)
Table 12 Canada Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 13 South America: Swollen Knee Treatment, by Type, 2020–2027 (USD
Million)
Table 14 South America: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 15 Europe: Swollen Knee Treatment, by Type, 2020–2027 (USD Million)
Table 16 Europe: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 17 Western Europe: Swollen Knee Treatment, by Type, 2020–2027 (USD
Million)
Table 18 Western Europe: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 19 Eastern Europe: Swollen Knee Treatment, by Type, 2020–2027 (USD
Million)
Table 20 Eastern Europe: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 21 Asia-Pacific: Swollen Knee Treatment, by Type, 2020–2027 (USD
Million)
Table 22 Asia-Pacific: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 23 Middle East & Africa: Swollen Knee Treatment, by Type, 2020–2027
(USD Million)
Table 24 Middle East & Africa Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Swollen Knee Treatment
Figure 3 Segmentation Market Dynamics for Global Swollen Knee Treatment
Figure 4 Global Swollen Knee Treatment Share, by Type, 2020
Figure 5 Global Swollen Knee Treatment Share, by Structure, 2020
Figure 6 Global Swollen Knee Treatment Share, by Application, 2020
Figure 7 Global Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Figure 8 Global Swollen Knee Treatment Share, by Region, 2020
Figure 9 North America: Swollen Knee Treatment Share, by Country, 2020
Figure 10 Europe: Swollen Knee Treatment Share, by Country, 2020
Figure 11 Asia-Pacific: Swollen Knee Treatment Share, by Country, 2020
Figure 12 Middle East & Africa: Swollen Knee Treatment Share, by Country, 2020
Figure 13 Global Swollen Knee Treatment: Company Share Analysis, 2020 (%)
Figure 14 Stryker Corporation: Key Financials
Figure 15 Stryker Corporation: Segmental Revenue
Figure 16 Stryker Corporation: Geographical Revenue
Figure 17 Zimmer Holdings: Key Financials
Figure 18 Zimmer Holdings: Segmental Revenue
Figure 19 Zimmer Holdings: Geographical Revenue
Figure 20 Smith & Nephew Plc.: Key Financials
Figure 21 Smith & Nephew Plc.: Segmental Revenue
Figure 22 Smith & Nephew Plc.: Geographical Revenue
Figure 23 DePuy Companies, Inc.: Key Financials
Figure 24 DePuy Companies, Inc.: Segmental Revenue
Figure 25 DePuy Companies, Inc.: Geographical Revenue
Figure 26 Wright Medical Group Inc.: Key Financials
Figure 27 Wright Medical Group Inc.: Segmental Revenue
Figure 28 Wright Medical Group Inc.: Geographical Revenue
Figure 27 Biomet Inc.: Key Financials
Figure 30 Biomet Inc.: Segmental Revenue
Figure 31 Biomet Inc.: Geographical Revenue
Figure 32 Exactech: Key Financials
Figure 33 Exactech: Segmental Revenue
Figure 34 Exactech: Geographical Revenue
Figure 35 B. Braun Melsungen AG: Key Financials
Figure 36 B. Braun Melsungen AG: Segmental Revenue
Figure 37 B. Braun Melsungen AG: Geographical Revenue
Figure 38 Pfizer Pharmaceuticals Inc.: Key Financials
Figure 37 Pfizer Pharmaceuticals Inc.: Segmental Revenue
Figure 40 Pfizer Pharmaceuticals Inc.: Geographical Revenue
Figure 41 Merck & Co.: Key Financials
Figure 42 Merck & Co.: Segmental Revenue
Figure 43 Merck & Co.: Geographical Revenue
Figure 44 Fresenius Kabi: Key Financials
Figure 45 Fresenius Kabi: Segmental Revenue
Figure 46 Fresenius Kabi: Geographical Revenue
Figure 47 AngioDynamics: Key Financials
Figure 48 AngioDynamics: Segmental Revenue
Figure 47 AngioDynamics: Geographical Revenue
Figure 50 C.R.Bard: Key Financials
Figure 51 C.R.Bard: Segmental Revenue
Figure 52 C.R.Bard: Geographical Revenue
Figure 53 Teleflex: Key Financials
Figure 54 Teleflex: Segmental Revenue
Figure 55 Teleflex: Geographical Revenue
Figure 56 Smiths Medical: Key Financials
Figure 57 Smiths Medical: Segmental Revenue
Figure 58 Smiths Medical: Geographical Revenue
Swollen Knee Treatment Market Scenario
The swollen knee treatment market is expected to register a significant growth during the forecast period (2018–2023).
Knee swelling or occasionally mentioned as “water on the knee” is a condition where excess fluid gets accumulated in an around the knee joint. This conditions in medical terms are referred to as “knee effusion”. The swollen knee can result due to injuries such as torn ligament, cartilage tear or broken bones. The increasing number of geriatric populations followed by the rising frequency of musculoskeletal diseases, a growing number of surgeries undertaken is projected to grow the swollen knee treatment market. The operating procedure of knee replacement is inclusive of various steps taken to implant the artificial device and replacement of the damaged knee.
The swollen knee treatment market is anticipated to grow due to several factors such as the growing rate of elderly aged diseases like obesity, arthritis, osteoporosis, diabetes and sports-related injuries. Contrary, due to existing and upcoming advance technologies such as minimally invasive surgery and improved implant supplies are making it more broadly accepted even by the younger population.
In spite of being a widely used technique for curing extremely debilitating diseases, such as rheumatoid arthritis, the swollen knee treatment market is confronting some challenges such as financial slowdown which is avoiding the growth of the market. Other growth restraining factors of the swollen knee treatment market are intense competition, huge surgical cost, growing awareness for some non-surgical treatment methods such as exercises, shoe inserts, walking aids, weight loss programs, and painkiller medicines.
Segmentation
The swollen knee treatment market has been segmented on the basis of type and end-users.
On the basis of type, the market has been classified as medications, patient-controlled analgesia (PCA) pumps, nerve blocks, liposomal bupivacaine, and surgery. The medications have been segmented into opioids and corticosteroids and others. The surgery is segmented into arthrocentesis, arthroscopy and knee replacement. The knee replacement is further segmented into total knee replacement, unicompartmental knee replacement, and others.
On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, and others.
On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.
The European swollen knee treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The swollen knee treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The swollen knee treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Swollen Knee Treatment Market Share, by Region, 2017 (%)
Source: MRFR Analysis
In the swollen knee treatment market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures.
The European market is expected to hold the second largest market share. The market growth in this region can be attributed to the rising frequency of diabetes patients, increasing number of surgeries, and increasing demand for advanced treatment procedures are boosting the European market.
The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism.
The market in the Middle East and Africa is expected to account for the smallest share of the swollen knee treatment market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Key Players
Some of the key players in the swollen knee treatment market are Stryker Corporation, Zimmer Holdings, Smith & Nephew Plc., DePuy Companies Inc., Wright Medical Group Inc., Biomet Inc., Exactech, B. Braun Melsungen AG, Pfizer Pharmaceuticals Inc., Merck & Co., Fresenius Kabi, AngioDynamics, C.R.Bard ,Teleflex ,Smiths Medical.
Swollen Knee Treatment Market, by Type
- Medications
- Corticosteroids
- Opioids
- Others
- Patient-controlled analgesia (PCA) pumps
- Nerve blocks
- Liposomal bupivacaine
- Surgery
- Arthrocentesis
- Arthroscopy
- Knee replacement
- Total knee replacement
- Uni-compartmental knee replacement
- Others
Swollen Knee Treatment Market, by End-User
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Others
Swollen Knee Treatment Market, by Region
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Intended Audience
- Advanced Surgical Trainees
- Governmental Agency
- Educational Organizations
- Medical Device Manufacturers
- Research Institutes and Academic Centers
- Market Research and Consulting
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 2020-2027: Substantial CAGR |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Basis of type and End-users |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Stryker Corporation, Zimmer Holdings, Smith & Nephew Plc., DePuy Companies Inc., Wright Medical Group Inc., Biomet Inc., Exactech, B. Braun Melsungen AG, Pfizer Pharmaceuticals Inc., Merck & Co., Fresenius Kabi, AngioDynamics, C.R.Bard ,Teleflex ,Smiths Medical. |
| Key Market Opportunities |
|
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Swollen knee treatment market would be restrained by huge surgical cost, awareness of non-surgical treatment methods, such as exercises, weight loss programs, walking aids, shoe inserts, and painkiller medicines.
Swollen knee treatment market patient-controlled analgesia (PCA) pumps, medications, liposomal bupivacaine, nerve blocks, and surgery.
Swollen knee treatment market would include clinics, ambulatory surgery centers, hospitals, and others.
The companies are Zimmer Holdings, Stryker Corporation, DePuy Companies Inc., Smith & Nephew Plc., Biomet Inc., Wright Medical Group Inc., B. Braun Melsungen AG, Exactech, Merck & Co., Pfizer Pharmaceuticals Inc., AngioDynamics, C.R.Bard , Fresenius Kabi, Teleflex, and Smiths Medical.
North America is the largest swollen knee treatment market.
